1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Acute Agitation and Aggression Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Oral 1.2.3 Intramuscular Injection 1.2.4 Others 1.3 Market by Application 1.3.1 Global Acute Agitation and Aggression Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals & Ambulatory Surgical Centers 1.3.3 Psychiatric Care Facilities 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Acute Agitation and Aggression Treatment Market Perspective (2016-2027) 2.2 Acute Agitation and Aggression Treatment Growth Trends by Regions 2.2.1 Acute Agitation and Aggression Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Acute Agitation and Aggression Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Acute Agitation and Aggression Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Acute Agitation and Aggression Treatment Industry Dynamic 2.3.1 Acute Agitation and Aggression Treatment Market Trends 2.3.2 Acute Agitation and Aggression Treatment Market Drivers 2.3.3 Acute Agitation and Aggression Treatment Market Challenges 2.3.4 Acute Agitation and Aggression Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Acute Agitation and Aggression Treatment Players by Revenue 3.1.1 Global Top Acute Agitation and Aggression Treatment Players by Revenue (2016-2021) 3.1.2 Global Acute Agitation and Aggression Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Acute Agitation and Aggression Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Acute Agitation and Aggression Treatment Revenue 3.4 Global Acute Agitation and Aggression Treatment Market Concentration Ratio 3.4.1 Global Acute Agitation and Aggression Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Acute Agitation and Aggression Treatment Revenue in 2020 3.5 Acute Agitation and Aggression Treatment Key Players Head office and Area Served 3.6 Key Players Acute Agitation and Aggression Treatment Product Solution and Service 3.7 Date of Enter into Acute Agitation and Aggression Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Acute Agitation and Aggression Treatment Breakdown Data by Type 4.1 Global Acute Agitation and Aggression Treatment Historic Market Size by Type (2016-2021) 4.2 Global Acute Agitation and Aggression Treatment Forecasted Market Size by Type (2022-2027) 5 Acute Agitation and Aggression Treatment Breakdown Data by Application 5.1 Global Acute Agitation and Aggression Treatment Historic Market Size by Application (2016-2021) 5.2 Global Acute Agitation and Aggression Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Acute Agitation and Aggression Treatment Market Size (2016-2027) 6.2 North America Acute Agitation and Aggression Treatment Market Size by Type 6.2.1 North America Acute Agitation and Aggression Treatment Market Size by Type (2016-2021) 6.2.2 North America Acute Agitation and Aggression Treatment Market Size by Type (2022-2027) 6.2.3 North America Acute Agitation and Aggression Treatment Market Size by Type (2016-2027) 6.3 North America Acute Agitation and Aggression Treatment Market Size by Application 6.3.1 North America Acute Agitation and Aggression Treatment Market Size by Application (2016-2021) 6.3.2 North America Acute Agitation and Aggression Treatment Market Size by Application (2022-2027) 6.3.3 North America Acute Agitation and Aggression Treatment Market Size by Application (2016-2027) 6.4 North America Acute Agitation and Aggression Treatment Market Size by Country 6.4.1 North America Acute Agitation and Aggression Treatment Market Size by Country (2016-2021) 6.4.2 North America Acute Agitation and Aggression Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Acute Agitation and Aggression Treatment Market Size (2016-2027) 7.2 Europe Acute Agitation and Aggression Treatment Market Size by Type 7.2.1 Europe Acute Agitation and Aggression Treatment Market Size by Type (2016-2021) 7.2.2 Europe Acute Agitation and Aggression Treatment Market Size by Type (2022-2027) 7.2.3 Europe Acute Agitation and Aggression Treatment Market Size by Type (2016-2027) 7.3 Europe Acute Agitation and Aggression Treatment Market Size by Application 7.3.1 Europe Acute Agitation and Aggression Treatment Market Size by Application (2016-2021) 7.3.2 Europe Acute Agitation and Aggression Treatment Market Size by Application (2022-2027) 7.3.3 Europe Acute Agitation and Aggression Treatment Market Size by Application (2016-2027) 7.4 Europe Acute Agitation and Aggression Treatment Market Size by Country 7.4.1 Europe Acute Agitation and Aggression Treatment Market Size by Country (2016-2021) 7.4.2 Europe Acute Agitation and Aggression Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Acute Agitation and Aggression Treatment Market Size (2016-2027) 8.2 Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Type 8.2.1 Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Application 8.3.1 Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Region 8.4.1 Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Acute Agitation and Aggression Treatment Market Size (2016-2027) 9.2 Latin America Acute Agitation and Aggression Treatment Market Size by Type 9.2.1 Latin America Acute Agitation and Aggression Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Acute Agitation and Aggression Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Acute Agitation and Aggression Treatment Market Size by Type (2016-2027) 9.3 Latin America Acute Agitation and Aggression Treatment Market Size by Application 9.3.1 Latin America Acute Agitation and Aggression Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Acute Agitation and Aggression Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Acute Agitation and Aggression Treatment Market Size by Application (2016-2027) 9.4 Latin America Acute Agitation and Aggression Treatment Market Size by Country 9.4.1 Latin America Acute Agitation and Aggression Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Acute Agitation and Aggression Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Acute Agitation and Aggression Treatment Market Size (2016-2027) 10.2 Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Type 10.2.1 Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Application 10.3.1 Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Country 10.4.1 Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Eli Lilly and Company 11.1.1 Eli Lilly and Company Company Details 11.1.2 Eli Lilly and Company Business Overview 11.1.3 Eli Lilly and Company Acute Agitation and Aggression Treatment Introduction 11.1.4 Eli Lilly and Company Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) 11.1.5 Eli Lilly and Company Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Acute Agitation and Aggression Treatment Introduction 11.2.4 Pfizer Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) 11.2.5 Pfizer Recent Development 11.3 Ono Pharmaceutical 11.3.1 Ono Pharmaceutical Company Details 11.3.2 Ono Pharmaceutical Business Overview 11.3.3 Ono Pharmaceutical Acute Agitation and Aggression Treatment Introduction 11.3.4 Ono Pharmaceutical Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) 11.3.5 Ono Pharmaceutical Recent Development 11.4 Otsuka Holdings 11.4.1 Otsuka Holdings Company Details 11.4.2 Otsuka Holdings Business Overview 11.4.3 Otsuka Holdings Acute Agitation and Aggression Treatment Introduction 11.4.4 Otsuka Holdings Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) 11.4.5 Otsuka Holdings Recent Development 11.5 GlaxoSmithKline 11.5.1 GlaxoSmithKline Company Details 11.5.2 GlaxoSmithKline Business Overview 11.5.3 GlaxoSmithKline Acute Agitation and Aggression Treatment Introduction 11.5.4 GlaxoSmithKline Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) 11.5.5 GlaxoSmithKline Recent Development 11.6 Bristol-Myers Squibb 11.6.1 Bristol-Myers Squibb Company Details 11.6.2 Bristol-Myers Squibb Business Overview 11.6.3 Bristol-Myers Squibb Acute Agitation and Aggression Treatment Introduction 11.6.4 Bristol-Myers Squibb Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) 11.6.5 Bristol-Myers Squibb Recent Development 11.7 Johnson & Johnson 11.7.1 Johnson & Johnson Company Details 11.7.2 Johnson & Johnson Business Overview 11.7.3 Johnson & Johnson Acute Agitation and Aggression Treatment Introduction 11.7.4 Johnson & Johnson Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) 11.7.5 Johnson & Johnson Recent Development 11.8 H. Lundbeck A/S 11.8.1 H. Lundbeck A/S Company Details 11.8.2 H. Lundbeck A/S Business Overview 11.8.3 H. Lundbeck A/S Acute Agitation and Aggression Treatment Introduction 11.8.4 H. Lundbeck A/S Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) 11.8.5 H. Lundbeck A/S Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Acute Agitation and Aggression Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Oral Table 3. Key Players of Intramuscular Injection Table 4. Key Players of Others Table 5. Global Acute Agitation and Aggression Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Acute Agitation and Aggression Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Acute Agitation and Aggression Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Acute Agitation and Aggression Treatment Market Share by Regions (2016-2021) Table 9. Global Acute Agitation and Aggression Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Acute Agitation and Aggression Treatment Market Share by Regions (2022-2027) Table 11. Acute Agitation and Aggression Treatment Market Trends Table 12. Acute Agitation and Aggression Treatment Market Drivers Table 13. Acute Agitation and Aggression Treatment Market Challenges Table 14. Acute Agitation and Aggression Treatment Market Restraints Table 15. Global Acute Agitation and Aggression Treatment Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Acute Agitation and Aggression Treatment Market Share by Players (2016-2021) Table 17. Global Top Acute Agitation and Aggression Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Agitation and Aggression Treatment as of 2020) Table 18. Ranking of Global Top Acute Agitation and Aggression Treatment Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Acute Agitation and Aggression Treatment Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Acute Agitation and Aggression Treatment Product Solution and Service Table 22. Date of Enter into Acute Agitation and Aggression Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Acute Agitation and Aggression Treatment Market Size by Type (2016-2021) (US$ Million) Table 25. Global Acute Agitation and Aggression Treatment Revenue Market Share by Type (2016-2021) Table 26. Global Acute Agitation and Aggression Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Acute Agitation and Aggression Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Acute Agitation and Aggression Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Acute Agitation and Aggression Treatment Revenue Market Share by Application (2016-2021) Table 30. Global Acute Agitation and Aggression Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Acute Agitation and Aggression Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Acute Agitation and Aggression Treatment Market Size by Type (2016-2021) (US$ Million) Table 33. North America Acute Agitation and Aggression Treatment Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Acute Agitation and Aggression Treatment Market Size by Application (2016-2021) (US$ Million) Table 35. North America Acute Agitation and Aggression Treatment Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Acute Agitation and Aggression Treatment Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Acute Agitation and Aggression Treatment Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Acute Agitation and Aggression Treatment Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Acute Agitation and Aggression Treatment Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Acute Agitation and Aggression Treatment Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Acute Agitation and Aggression Treatment Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Acute Agitation and Aggression Treatment Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Acute Agitation and Aggression Treatment Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Acute Agitation and Aggression Treatment Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Acute Agitation and Aggression Treatment Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Acute Agitation and Aggression Treatment Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Acute Agitation and Aggression Treatment Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Acute Agitation and Aggression Treatment Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Acute Agitation and Aggression Treatment Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Country (2022-2027) & (US$ Million) Table 62. Eli Lilly and Company Company Details Table 63. Eli Lilly and Company Business Overview Table 64. Eli Lilly and Company Acute Agitation and Aggression Treatment Product Table 65. Eli Lilly and Company Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) & (US$ Million) Table 66. Eli Lilly and Company Recent Development Table 67. Pfizer Company Details Table 68. Pfizer Business Overview Table 69. Pfizer Acute Agitation and Aggression Treatment Product Table 70. Pfizer Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) & (US$ Million) Table 71. Pfizer Recent Development Table 72. Ono Pharmaceutical Company Details Table 73. Ono Pharmaceutical Business Overview Table 74. Ono Pharmaceutical Acute Agitation and Aggression Treatment Product Table 75. Ono Pharmaceutical Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) & (US$ Million) Table 76. Ono Pharmaceutical Recent Development Table 77. Otsuka Holdings Company Details Table 78. Otsuka Holdings Business Overview Table 79. Otsuka Holdings Acute Agitation and Aggression Treatment Product Table 80. Otsuka Holdings Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) & (US$ Million) Table 81. Otsuka Holdings Recent Development Table 82. GlaxoSmithKline Company Details Table 83. GlaxoSmithKline Business Overview Table 84. GlaxoSmithKline Acute Agitation and Aggression Treatment Product Table 85. GlaxoSmithKline Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) & (US$ Million) Table 86. GlaxoSmithKline Recent Development Table 87. Bristol-Myers Squibb Company Details Table 88. Bristol-Myers Squibb Business Overview Table 89. Bristol-Myers Squibb Acute Agitation and Aggression Treatment Product Table 90. Bristol-Myers Squibb Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) & (US$ Million) Table 91. Bristol-Myers Squibb Recent Development Table 92. Johnson & Johnson Company Details Table 93. Johnson & Johnson Business Overview Table 94. Johnson & Johnson Acute Agitation and Aggression Treatment Product Table 95. Johnson & Johnson Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) & (US$ Million) Table 96. Johnson & Johnson Recent Development Table 97. H. Lundbeck A/S Company Details Table 98. H. Lundbeck A/S Business Overview Table 99. H. Lundbeck A/S Revenue in Acute Agitation and Aggression Treatment Business (2016-2021) & (US$ Million) Table 100. H. Lundbeck A/S Recent Development Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Acute Agitation and Aggression Treatment Market Share by Type: 2020 VS 2027 Figure 2. Oral Features Figure 3. Intramuscular Injection Features Figure 4. Others Features Figure 5. Global Acute Agitation and Aggression Treatment Market Share by Application: 2020 VS 2027 Figure 6. Hospitals & Ambulatory Surgical Centers Case Studies Figure 7. Psychiatric Care Facilities Case Studies Figure 8. Others Case Studies Figure 9. Acute Agitation and Aggression Treatment Report Years Considered Figure 10. Global Acute Agitation and Aggression Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Acute Agitation and Aggression Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Acute Agitation and Aggression Treatment Market Share by Regions: 2020 VS 2027 Figure 13. Global Acute Agitation and Aggression Treatment Market Share by Regions (2022-2027) Figure 14. Global Acute Agitation and Aggression Treatment Market Share by Players in 2020 Figure 15. Global Top Acute Agitation and Aggression Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Agitation and Aggression Treatment as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Acute Agitation and Aggression Treatment Revenue in 2020 Figure 17. Global Acute Agitation and Aggression Treatment Revenue Market Share by Type (2016-2021) Figure 18. Global Acute Agitation and Aggression Treatment Revenue Market Share by Type (2022-2027) Figure 19. North America Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Acute Agitation and Aggression Treatment Market Share by Type (2016-2027) Figure 21. North America Acute Agitation and Aggression Treatment Market Share by Application (2016-2027) Figure 22. North America Acute Agitation and Aggression Treatment Market Share by Country (2016-2027) Figure 23. United States Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Acute Agitation and Aggression Treatment Market Share by Type (2016-2027) Figure 27. Europe Acute Agitation and Aggression Treatment Market Share by Application (2016-2027) Figure 28. Europe Acute Agitation and Aggression Treatment Market Share by Country (2016-2027) Figure 29. Germany Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Acute Agitation and Aggression Treatment Market Share by Type (2016-2027) Figure 37. Asia-Pacific Acute Agitation and Aggression Treatment Market Share by Application (2016-2027) Figure 38. Asia-Pacific Acute Agitation and Aggression Treatment Market Share by Region (2016-2027) Figure 39. China Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Acute Agitation and Aggression Treatment Market Share by Type (2016-2027) Figure 47. Latin America Acute Agitation and Aggression Treatment Market Share by Application (2016-2027) Figure 48. Latin America Acute Agitation and Aggression Treatment Market Share by Country (2016-2027) Figure 49. Mexico Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Acute Agitation and Aggression Treatment Market Share by Type (2016-2027) Figure 53. Middle East & Africa Acute Agitation and Aggression Treatment Market Share by Application (2016-2027) Figure 54. Middle East & Africa Acute Agitation and Aggression Treatment Market Share by Country (2016-2027) Figure 55. Turkey Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Acute Agitation and Aggression Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Eli Lilly and Company Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2016-2021) Figure 59. Pfizer Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2016-2021) Figure 60. Ono Pharmaceutical Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2016-2021) Figure 61. Otsuka Holdings Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2016-2021) Figure 62. GlaxoSmithKline Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2016-2021) Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2016-2021) Figure 64. Johnson & Johnson Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2016-2021) Figure 65. H. Lundbeck A/S Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Eli Lilly and Company Pfizer Ono Pharmaceutical Otsuka Holdings GlaxoSmithKline Bristol-Myers Squibb Johnson & Johnson H. Lundbeck A/S